|Home | About | Journals | Submit | Contact Us | Français|
studies suggest that folate deficiency may occur in up to one third of
patients with severe depression, and that treatment with the vitamin
may enhance recovery of the mental state. There are, however,
difficulties in interpreting serum and red cell folate assays in some
patients, and it has been suggested that total plasma homocysteine is a
more sensitive measure of functional folate (and vitamin B12)
deficiency. Other studies suggest a link between folate deficiency and
impaired metabolism of serotonin, dopamine, and noradrenaline
(norepinephrine), which have been implicated in mood disorders. A study
of homocysteine, folate, and monoamine metabolism has, therefore, been
undertaken in patients with severe depression.
METHODS—In 46 inpatients with severe DSM III depression, blood counts, serum and red cell folate, serum vitamin B12, total plasma homocysteine, and, in 28 patients, CSF folate, S-adenosylmethionine, and the monoamine neurotransmitter metabolites 5HIAA, HVA, and MHPG were examined. Two control groups comprised 18 healthy volunteers and 20 patients with neurological disorders, the second group undergoing CSF examination for diagnostic purposes.
RESULTS—Twenty four depressed patients (52%) had raised total plasma homocysteine. Depressed patients with raised total plasma homocysteine had significant lowering of serum, red cell, and CSF folate, CSF S-adenosylmethionine and all three CSF monoamine metabolites. Total plasma homocysteine was significantly negatively correlated with red cell folate in depressed patients, but not controls.
CONCLUSIONS—Utilising total plasma homocysteine as a sensitive measure of functional folate deficiency, a biological subgroup of depression with folate deficiency, impaired methylation, and monoamine neurotransmitter metabolism has been identified. Detection of this subgroup, which will not be achieved by routine blood counts, is important in view of the potential benefit of vitamin replacement.